Bipolar disorder is one of the most clinically complex mood conditions to treat — not because it is poorly understood, but because its depressive phase presents a specific pharmacological challenge that standard antidepressants are poorly equipped to address. At Minnesota Ketamine & Wellness Institute, we treat bipolar disorder with ketamine infusion therapy, and we want to explain clearly what the evidence says, what the treatment involves, and what patients with this diagnosis should know before exploring their options.
Understanding Bipolar Disorder
Bipolar disorder is a mood condition characterized by episodes of significant mood elevation — mania or hypomania — alternating with episodes of depression. The National Institute of Mental Health describes several types of bipolar disorder, distinguished by the severity and pattern of mood episodes: Bipolar I, which involves full manic episodes that may require hospitalization; Bipolar II, which involves hypomanic episodes that are less severe than full mania but are paired with significant depressive episodes; and Cyclothymic Disorder, which involves periods of hypomanic and depressive symptoms that do not meet the full diagnostic threshold for either. All types share the core feature of mood cycling, though the pattern, severity, and frequency differ considerably by individual.
The depressive phase of bipolar disorder deserves particular attention in any discussion of treatment options, because it is the phase during which most functional impairment occurs and during which most patients seek care. Bipolar depression — the experience of a major depressive episode within the context of a bipolar diagnosis — is distinct from unipolar depression in clinically important ways. Standard antidepressants, which are the first-line treatment for unipolar depression, carry a risk of triggering manic or hypomanic episodes in patients with bipolar disorder, which is why treatment of bipolar depression typically involves mood stabilizers, atypical antipsychotics, and careful medication management rather than antidepressant monotherapy.
Why Bipolar Depression Is Particularly Difficult to Treat
The treatment gap in bipolar depression is substantial. Many patients spend significantly more time in the depressive phase than in the manic or hypomanic phase, and the available medications for bipolar depression — while meaningful — do not work adequately for every patient. For patients whose depressive episodes are severe, frequent, or treatment-resistant, the need for additional options is real.
This is where ketamine’s mechanism becomes clinically relevant. Standard medications for bipolar depression primarily target serotonin, dopamine, or norepinephrine pathways. Ketamine acts on the glutamate system — specifically on NMDA receptors, the N-methyl-D-aspartate receptors that regulate synaptic plasticity and neural communication — through a pathway that existing bipolar medications do not directly address. Peer-reviewed research examines ketamine’s potential for treating bipolar depression and other mood conditions, documenting findings that are meaningful for patients who have not found adequate relief through standard approaches (National Institutes of Health). Results vary by individual, and ketamine is not appropriate for every patient with a bipolar diagnosis — suitability is assessed carefully at intake.
What the Research Shows
Research from the National Institute of Mental Health provides a specific finding that is particularly relevant for patients with bipolar depression: ketamine has been shown to rapidly restore pleasure-seeking behavior — addressing anhedonia, the inability to experience pleasure — ahead of other antidepressant actions. Anhedonia is one of the most debilitating symptoms of bipolar depression and one of the most difficult to address through conventional pharmacological means. The speed with which ketamine may reach this symptom — within hours rather than weeks — represents a meaningful clinical distinction for patients who have experienced the toll that prolonged depressive episodes take on functioning and quality of life.
The mechanism behind this rapid effect involves neuroplasticity — the brain’s capacity to form and reorganize neural connections. Depression, including bipolar depression, degrades the neural pathways that support mood regulation and adaptive thinking. By blocking NMDA receptors and promoting neuroplasticity, ketamine may help restore those pathways in ways that mood stabilizers and antipsychotics, which operate through different mechanisms, do not directly accomplish.
What Treatment Looks Like at Our Clinic
At Minnesota Ketamine & Wellness Institute, bipolar disorder is treated with IV ketamine infusions. The standard protocol is six infusions administered over two to three weeks, with each infusion running 40 minutes. The first appointment, which includes intake assessment and provider orientation, requires approximately one and a half to two hours. Subsequent appointments run approximately one hour each, including a 30-minute post-infusion recovery period.
The intake process for patients with bipolar disorder involves careful attention to current medications and to the patient’s full mood history. Our Medical Director, a psychiatrist with over 26 years of clinical experience, and our psychiatric nurse practitioners oversee medication management and treatment planning for patients whose care requires coordination across mood-stabilizing regimens and ketamine infusions. We evaluate the full clinical picture before proceeding — bipolar disorder introduces specific considerations that require individualized assessment rather than a standardized intake.
A meaningful component of that assessment is reviewing which medications may affect ketamine’s efficacy. Daily benzodiazepines and Lamictal at doses above 100mg per day are two examples of medications that can interfere with how well ketamine works — factors we identify and address at intake rather than after the fact.
The Role of Medication Management
For many patients with bipolar disorder, ketamine infusions are not a replacement for their existing medication regimen — they are an addition to it, aimed at addressing the depressive phase more effectively. Our clinic offers medication management services with our psychiatric nurse practitioners, available in Maple Grove and Rochester, Minnesota, with both in-person and telehealth appointment options. For patients whose bipolar disorder involves complex or evolving medication needs, having medication management and ketamine infusion services under one roof allows for coordinated, responsive care.
This coordination matters clinically. Adjustments to a mood stabilizer or antipsychotic during a ketamine series — or vice versa — can affect both efficacy and safety, and those decisions benefit from being made by a team with visibility into the full treatment picture. Discuss with your provider at intake how your existing medications and any planned changes will be factored into your treatment plan.
Integration Therapy for Bipolar Disorder
For patients with bipolar disorder who want to address the emotional and psychological dimensions of the condition alongside medical treatment, our clinic offers preparation and integration psychotherapy as a separate, complementary service. Our licensed therapists hold credentials in trauma-informed care, cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and somatic approaches — all modalities with established relevance for mood disorders. The combination of ketamine infusions and structured psychotherapy may support more durable outcomes than either approach alone, though individual results vary.
Integration therapy is optional, not required. Whether it makes sense for a given patient depends on their history, their goals, and how much of their experience with bipolar disorder involves trauma, relational difficulty, or patterns that therapeutic work might address. That conversation starts at the consultation.
Addressing the Fear of Treatment Complexity
Patients with bipolar disorder often come to us after years of medication trials, mood monitoring, and the particular exhaustion that comes from managing a condition that cycles. The idea of adding another treatment — particularly one that involves a dissociative experience — can feel like more complexity on top of an already complex situation.
We hear this consistently, and we want to name it directly: the intake process at our clinic is designed to account for that complexity, not to paper over it. Our providers spend significant time at the first appointment understanding your full history — what has worked, what has not, and what the patterns of your mood cycling have looked like over time. Ketamine infusions are not pursued hastily for patients with bipolar disorder. Suitability is assessed carefully, the medication picture is reviewed thoroughly, and the decision to proceed is made collaboratively with you.
Addressing the Cost Barrier
Ketamine infusion therapy is an out-of-pocket expense for most patients. The initial series of six infusions is $500 per infusion; maintenance infusions, which most patients pursue after the initial series, are $400 per infusion. Most HSA and FSA accounts are accepted as a form of payment, and a $250 service discount is available for military personnel, law enforcement officers, and front-line workers who qualify. Payment is made on a per-session basis — the full series does not need to be paid in advance.
Frequently Asked Questions
Is ketamine safe for people with bipolar disorder? Ketamine can be used in patients with bipolar disorder, but suitability requires careful individual assessment. The intake evaluation at our clinic includes a full review of mood history, current medications, and clinical presentation before any infusion is scheduled. Not every patient with a bipolar diagnosis will be a candidate — that determination is made on an individualized basis, not by diagnostic category alone.
Will ketamine trigger a manic episode? This is one of the most important questions for patients with bipolar disorder to raise at intake, and we take it seriously. Available research on ketamine in bipolar depression is evaluated on an individual basis. If your history includes rapid cycling, recent manic or hypomanic episodes, or specific medication combinations that require careful monitoring, those factors are part of the intake assessment. Discuss your full mood history with your provider before treatment begins.
Can I continue my mood stabilizer or antipsychotic while receiving ketamine infusions? In many cases, yes — but this depends on which medications you are taking and at what doses. Some medications interact with ketamine in ways that affect efficacy or require adjustment. Others are compatible with concurrent use. This is reviewed thoroughly at intake, and medication decisions are made collaboratively with your provider based on your individual situation.
How is ketamine different from the medications I’m already taking for bipolar disorder? Most medications used for bipolar disorder — mood stabilizers and atypical antipsychotics — work on dopamine, serotonin, or related pathways. Ketamine acts on the glutamate system through NMDA receptor modulation, which is a distinct mechanism that existing bipolar medications do not directly address. For patients whose depressive phase has not responded adequately to standard treatments, this different mechanism is the clinical rationale for exploring ketamine.
Is SPRAVATO® an option for bipolar depression? SPRAVATO® (esketamine nasal spray) is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior — it does not currently hold a specific FDA approval for bipolar depression. Whether SPRAVATO® is appropriate for a patient with a bipolar diagnosis is a clinical question that should be discussed with your provider, taking into account your full diagnostic and medication history.
Key Takeaways
- Bipolar disorder involves alternating mood episodes; the depressive phase produces most functional impairment and is the most difficult to treat with standard medications.
- Ketamine acts on the glutamate system through NMDA receptor modulation — a pathway distinct from mood stabilizers and antipsychotics — and may help address bipolar depression in patients who have not responded adequately to existing treatments; results vary by individual.
- Research from the National Institute of Mental Health shows ketamine can rapidly restore pleasure-seeking behavior in patients with bipolar depression, a finding relevant to one of the condition’s most disabling symptoms.
- Medication management is available at our clinic alongside ketamine infusions, allowing for coordinated care across a patient’s full treatment plan.
- Suitability for ketamine therapy in bipolar disorder is assessed individually at intake — diagnostic category alone does not determine candidacy.
Bipolar depression is not a condition that yields easily to any single treatment, and we do not suggest that ketamine changes that. What it may offer — for the right patient, assessed carefully and treated in coordination with their existing care — is a meaningfully different mechanism of action aimed at the depressive phase that standard approaches often leave inadequately addressed. Call us at 612-502-2800 or complete the consultation form on our website to schedule a consultation and discuss whether ketamine therapy may be a fit for where you are in your treatment.
References
- National Institutes of Health. Ketamine and bipolar disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC10098148/
- National Institute of Mental Health. Rapid agent restores pleasure-seeking ahead of other antidepressant action. https://www.nimh.nih.gov/news/science-updates/2014/rapid-agent-restores-pleasure-seeking-ahead-of-other-antidepressant-action
- National Institute of Mental Health. Bipolar disorder. https://www.nimh.nih.gov/health/topics/bipolar-disorder
Medical Disclaimer: The information in this blog is provided for educational purposes only and does not constitute medical advice. Ketamine infusion therapy for bipolar disorder at Minnesota Ketamine & Wellness Institute should only be pursued under the supervision of a licensed provider familiar with your complete medical and psychiatric history, including your full mood history and current medication regimen. Individual results vary. This content does not address every clinical consideration relevant to ketamine therapy in the context of bipolar disorder — a thorough intake evaluation is required before any treatment begins. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.